The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data.
 
Kumiko Umemoto
Honoraria - Taiho Pharmaceutical
 
Hiroyuki Yamamoto
No Relationships to Disclose
 
Ritsuko Oikawa
No Relationships to Disclose
 
Hiroyuki Takeda
Honoraria - Bristol-Myers Squibb Japan; Taiho Pharmaceutical
 
Ayako Doi
Honoraria - Taiho Pharmaceutical
 
Yoshiki Horie
No Relationships to Disclose
 
Takashi Ogura
No Relationships to Disclose
 
Takuro Mizukami
Honoraria - Asahi Kasei; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Merck; Otsuka; Taiho Pharmaceutical; Takeda
Research Funding - Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Naoki Izawa
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
 
Jay A. Moore
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Ethan Sokol
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Yu Sunakawa
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Kyowa Hakko Kirin; Lilly Japan; Merck; MSD K.K; Nippon Kayaku; Sanofi; Sysmex; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bristol-Myers Squibb Japan; MSD K.K; Takeda
Research Funding - Chugai Pharma; Lilly Japan; Nihonkayaku; Otsuka; Sanofi; Taiho Pharmaceutical; Takeda